The University of Texas Health Science Center at San Antonio Listed a New Clinical Trial to Study the Effects of mTOR Inhibition with Sirolimus (RAPA) in Patients with COVID-19 to Moderate the Progression of ARDS

Press/Media: Press / Media

PeriodJul 22 2020

Media coverage

1

Media coverage

  • TitleThe University of Texas Health Science Center at San Antonio Listed a New Clinical Trial to Study the Effects of mTOR Inhibition with Sirolimus (RAPA) in Patients with COVID-19 to Moderate the Progression of ARDS
    Media name/outletIndia Pharma News
    CountryIndia
    Date7/22/20
    PersonsDean L Kellogg Jr